Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like IGPK is going to pay for your next few trips down here... with all the frills...of course....lol
enjoy the sun...nice in Sarasota too.....good to see you here
And...how is the new Grandbaby?
More like VIRT....he popped up a cuple days ago
exactly.......
Stevec thanks for all the great info...question though sugar contracts...chicken feet aside...Just having the licencing through the GACC and Bureau of Import and Export Food Safety in China to be able to sell products in China....that's got to be worth quite a lot....don't you think? .... I would ..... thanks in advance and again great info
Make that 1,000,000 Shares trade premarket
820,961 shares traded pre-market
good news...it is a a very good price point at present...so you really didn't miss it
ps....they are current https://www.otcmarkets.com/stock/BORK/disclosure
good to see a little action here on the board...BIG Things coming
but to some here....that doesn't mean anything.....right?
Quarterly's filed today afterhours https://www.otcmarkets.com/stock/BORK/disclosure
but lets see how many will say this means nothing as well
https://bourqueindustries.com/ NEW WEBSITE UP
When it DOES happen... I can't wait to see all the positive posts here....................
they already have a trial ongoing currently for a vaccine and another commencing in jan/22
Emergex obtains approval to commence Phase I trial of Covid-19 vaccine
16 Nov 2021 (Last Updated November 16th, 2021 15:50)
Subject dosing in the trial to assess safety and tolerability of the vaccine will begin in January next year.
Share Article
Emergex Vaccines has obtained regulatory approvals to commence the Phase I clinical trial of its Covid-19 vaccine candidate.
The double-blind, randomised, comparator-controlled trial will analyse the safety and tolerability of high and low doses of the vaccine.
To be conducted by the University of Lausanne, Switzerland Center for Primary Care and Public Health professor Blaise Genton, the trial will enrol a total of 13 subjects into two groups.
The company expects to dose the first subject with the first dose of the vaccine in January 2022.
Apart from safety and tolerability, the trial will offer information on CD8+ T-Cell-facilitated immune responses as a measure of protection against SARS-CoV-2 infection.
Emergex Vaccines chief commercial officer Robin Cohen said: “Our T Cell priming vaccines may offer significant benefits over current Covid-19 vaccines, including longer-lasting immunity and broader protection against new variants.
“We are proud to announce the initiation of this trial and look forward to gathering data to support the development of this important next-generation vaccine.”
The company is currently carrying out another Phase I trial of its dengue vaccine candidate in Switzerland.
previous custo's by the v group (as you refer to them) have Not worked out that way.....although the theatrical approach you use is I guess entertaining....including the true Brooklyn approach to the judge saying no.... for entertainment value ....I give it an 8.5
JB coming through will be the best I agree and probably quicker ( hope I didn't catch you with a mouth full of coffee)
Time reveals all....good luck today
https://www.otcmarkets.com/stock/TIPS/profile
profile updated today as well....
keep in mind the judge dismissed the custo case without Prejudice....meaning they can file again...and if it comes to that....they will get it next time
OR
we get things going without them...JB actually coming through with something of substance
either way I think we will be golden here
By virtue of this acquisition, Wilton now holds 59% of TIPS common stock.
Authorized Shares
200,000,000
12/03/2021
Outstanding Shares
84,672,907
12/03/2021
Restricted
63,593,196
12/03/2021
Unrestricted
21,079,711
12/03/2021
Held at DTC
16,583,583
12/03/2021
Float
Not Available
may I sticky this post?
who grabbed the dip today....congrats in advance
dollar coming.........
From their Twitter page
TIPS Investor Relations
@TIPSInvest
·
57m
Wilton already has two major acquisitions/investments for TIPS ready to go and a third just completing the due diligence process. These acquisitions will not only take TIPS to OTCQB or OTCQX, but potentially to NASDAQ.
in at .25 can't wait til Monday
decent finish...hod was .0145
we go Pink Current....and can only muster 4 messages...2 of which were negative
tough crowd
nothing....not a word about the end of day trading today...
I think a lot of folks here are gun shy (for good reasons) and there are always two separate and different forces moving the price in the direction...they....want it to go...in order to benefit them
some want it to go up...so they can get out...some want it to go down ...to get a better price
thoughts on how soon this will go pink current...everything seems to have been filed in order to be so
niceeeee. good eye
lol just got this ...just a shareholder
I see that you have been here for a very long time so I understand your frustration.
Hopefully the events that are taking place or attempting to will turn this around for you.
why do you think the 2 atty letters were filed...? asking not arguing
Additional Atty letter out today
https://www.otcmarkets.com/otcapi/company/financial-report/309179/content
Bid moving up both in price and size
still shocked how quiet it is here
KAVL is one that is presently at 1.72 and traded as as 13.38
personally I'll take either...but the 13.38 looks pretty sweet
this will be one a lot of people will be talking about
soooooo, what everyone is saying is....we haven't seen these prices for a while..
win big and lose small